Coenzyme Q-10 |
Co Q 10; Mitoquinone; Q 10; Ubidecarenone; Ubiquinone; Vitamin Q |
Clinical Trial: Funen Anorexia Nervosa Study - Retrospective Cohort Study and 10 Year Follow-Up Study
This study is not yet open for patient recruitment.
Verified by Odense University Hospital December 2005
|
Purpose
The aim of the study are:
- Retrospectively to study the clinical characteristics and features (somatic, psychological and social variables) of patients treated in Center for Eating Disorders, Odense University Hospital 1994-2004.
- To study the predictive power of the psychosocial and morphometric data with regard to drop outs, relapse and outcome.
- To investigate eating habits, social functions and quality of life in weight recovered and chronicly ill patients with eating disorder.
| Condition | Phase |
|---|---|
| Anorexia Nervosa Eating Disorder | Phase I |
MedlinePlus related topics: Eating Disorders
Study Type: Observational
Study Design: Longitudinal, Defined Population, Retrospective Study
Study start: January 2006
Eligibility
Inclusion Criteria:
Patients treated in Center for Eating Disorders, Odense University Hospital 1994 – 2004.
Exclusion Criteria:
- Patients, who according to the primary clinical evaluation was found not to suffer from eating disorder.
- Patients who at admission did not live in the Funen County.
Location and Contact Information
Denmark
Odense University Hospital, Odense, 5000, Denmark
René K. Stovring, MD, PhD, Principal Investigator, Odense University Hospital
More Information
Last Updated: December 19, 2005
Record first received: December 19, 2005
ClinicalTrials.gov Identifier: NCT00267228
Health Authority: Denmark: National Board of Health
ClinicalTrials.gov processed this record on 2006-01-10
Resources
- Co Q 10 (Drug Digest)
- Coenzyme Q-10 (Drug Digest)

Not Signed In -

